SLCO1B1 Gene Polymorphisms (rs2306283 and rs4149056) and Statin-Induced Myopathy in Jordanian Diabetics.
CONCLUSIONS: Genetic polymorphism in the SLCO1B1 Gene is a risk factor for the development of SIM in Jordanian patients.
PMID: 32860365 [PubMed - as supplied by publisher]
Source: Current Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Shahrure ZM, Irshaid YM, Mustafa KN, Abujbara MA, Al Shhab M, El-Khateeb MS, Ajlouni KM Tags: Curr Clin Pharmacol Source Type: research
More News: Cholesterol | Diabetes | Drugs & Pharmacology | Endocrinology | Genetics | Jordan Health | Middle East Health | Organic | Statin Therapy | Study